Blogs
News
PR
- Blogs
Drug discovery and biomolecular research often come down to a simple question: how well do these two molecules interact? There are two major ways to answer that question - direct binding assays and competition (displacement) assays - and each...
In the world of biomedical research and drug discovery, having an understanding of how molecules interact is imperative to expanding our knowledge of the inner workings of complex biological systems, as well as accelerating drug discovery....
In biological contexts, oligomerization is primarily driven by the self-assembly of monomers via non-covalent interactions - including hydrogen bonds, ionic interactions and van der Waals forces [3]. Such interactions may be influenced by co-factors ...
In this article, we’ll look at three key considerations for characterising amyloid fibrils, along with practical tips to help you avoid common pitfalls and improve the reliability of your findings.
In this post, we’ll cover what amyloid fibrils are, why studying them matters, and how different methods compare in revealing their complex behaviour.
To truly understand the nature and significance of a protein-protein interaction (PPI), you need to go beyond the dissociation constant. In this article, we’ll explore why KD alone doesn’t tell the whole story, what other measurements can add to ...
- News
Cambridge, UK, 2 September 2025: Fluidic Sciences Ltd, a leader in in‑solution protein interaction analysis, today announced it has purchased the business and assets of Sphere Bio Ltd.
Hertfordshire, UK – 20 May 2024. Fluidic Sciences Ltd., today announces its official launch as a company, and the commercial relaunch of the acquired Fluidity One-M instrument for measuring protein-protein interactions in solution—leveraging...
- PR
MDS can enhance the information gained from an assay experiment and allow the timely and guided production of novel protein and antibody-based therapeutics...
After its recent launch, Fluidic Sciences is debuting the acquired Fluidity One-M instrument for measuring protein-protein interactions in solution — leveraging Microfluidic Diffusional Sizing (MDS) technology.
Fluidic Sciences said on Monday that it has acquired technology developed by defunct protein research firm Fluidic Analytics and ...
A new business operating globally out of Cambridge has been formed by entrepreneurs David Newble and Mark Gilligan to identify opportunities for growth at young techbio ventures that need guidance and finance to grow.